You just read:

Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation

News provided by

Arena Pharmaceuticals, Inc.

Mar 08, 2019, 08:30 ET